Turkish Abstract Full Text PDF Similar Articles Mail to Author

Erciyes Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Medikal Onkoloji Bilim Dalı Small cell lung cancer (SCLC) is distinguished by non-small cell lung cancer (NSCLC) by its' biological behaviour, management and prognosis. As the disease is commonly in extended form and distant metastasis and regional lymph node involvement are present at the time of diagnosis SCLC is assumed as a systemic disease. Studies concerning with understanding the molecular and genetic characteristics of the disease may change the treatment modalities. Despite the efforts to develope new and effective treatment options, standart management of limited disease remained unchanged during the last fifteen years. On the other hand there are ongoing studies for the treatment of extended disease. However, prevention of cigarette smoking is still the best practice. Keywords : Small cell lung cancer; chemotherapy